Transient selection during vaccinia virus recombination with insertion vectors without selectable markers

BioTechniques

Volumn 22, Issue 5, 1997, Pages 906-910

  Kurilla, Michael G ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLONING VECTOR; DNA TRANSFECTION; GENE INSERTION; MARKER GENE; NONHUMAN; VACCINIA VIRUS; VIRUS RECOMBINATION;

VACCINIA; VACCINIA VIRUS;

EID: 0030956860     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/97225st03     Document Type: Article

References (20)

1. Blasco, R. and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
2. Boyle, D.B. and B.E. Coupar. 1988. A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123-128.
3. Chakrabati, S., K. Brechling and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5:3403-3409.
4. Coupar, B.E.H., M.E. Andrew and D.B. Boyle. 1988. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68:1-10.
5. Falkner, F.G. and B. Moss. 1988. Escherichia coli gpt gene provides dominant selection tor vaccinia virus open reading frame expression vectors. J. Virol. 62:1849-1854.
6. Falkner, F.G. and B. Moss. 1990. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:3108-3111.
7. Flexner, C., A. Hugin and B. Moss. 1987. Prevention of vaccinia virus infection in imnumodeficient mice by vector-directed IL-2 expression. Nature 330:259-262.
8. Flexner, C. and B. Moss. 1990. Vaccinia as a live vector carrying cloned foreign genes, p. 189-206. In G.C. Woodrow and M.M. Levine (Eds.), New Generation Vaccines. Marcel Dekker, New York.
9. Isaacs, S.N., G.J. Kotwal and B. Moss. 1990. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology 178:626-630.
10. Mackett, M., G.L. Smith and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foriegn genes. J. Virol. 49:857-864.
11. Mackett, M., G.L. Smith and B. Moss. 1985. The construction and characterization of vaccinia virus recombinants expressing foreign genes, p. 191-211. In D.M. Glover (Ed.), DNA Cloning Volume II. A Practical Approach. IRL Press Limited, Washington DC.
12. Moss, B. 1991. Vaccinia virus: a tool for research and vaccine development. Science 252:1662-1667.
13. Moss, B. and C. Flexner. 1987. Vaccinia virus expression vectors. Annu. Rev. Immunol. 5:305-324.
14. Murray, R.J., M.G. Kurilla, H.M. Griffin, J.M. Brooks, M. Mackett, J.R. Arrand, M. Rowe, S.R. Burrows et al. 1990. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc. Natl. Acad. Sci. USA 87:2906-2910.
15. Panicali, D., A. Grzelecki and C. Huang. 1986. Vaccinia virus vectors utilizing the β-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene 47:193-199.
16. Pasamontes, L., J. Gubser, R. Wittek and G.J. Viljoen. 1991. Direct identification of recombinant vaccinia virus plaques by PCR. J. Virol. Methods 35:137-141.
17. Patel, D.D., C.A. Ray, R.P. Drucker and D.J. Pickup. 1988. A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells. Proc. Natl. Acad. Sci. USA 85:9431-9435.
18. Piccini, A., M.E. Perkus and E. Paoletti. 1987. Vaccinia virus as an expression vector. Methods Enzymol. 153:545-563.
19. Southern, P.J. and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
20. Turner, P.C. and R.W. Moyer. 1992. A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning. BioTechniques 13:764-771.